Insider Trading November 19, 2026 07:00 PM

AEye Director Husby Adds 35,860 Shares Near 52-Week Low

The insider purchase, valued at $25,058, comes as the lidar maker trades around $0.69 and reports mixed third-quarter results.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
LIDR

AEye director Jonathon B. Husby purchased 35,860 shares of the company's common stock on November 19, 2026, at prices between $0.6900 and $0.7050, for a total of $25,058. The transaction lifts his direct holdings to 130,468 shares. The buy occurs as AEye's stock trades near its 52-week low of $0.67 and has fallen roughly 71% over the past year. The company recently reported third-quarter 2026 results that beat earnings expectations but missed revenue forecasts, while also highlighting its strongest commercial quarter to date. Separately, AEye's board approved a 2027 executive equity program consisting of performance stock units and time-based restricted stock units for certain executives.

AEye Director Husby Adds 35,860 Shares Near 52-Week Low
LIDR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Jonathon B. Husby bought 35,860 AEye shares at $0.6900-$0.7050, bringing his direct holdings to 130,468 shares.
  • The purchase comes as LIDR trades near its 52-week low of $0.67 and is down about 71% over the past year.
  • AEye's Q3 2026 results beat EPS estimates but missed revenue, while the company highlighted its strongest commercial quarter.
  • The board approved a 2027 executive equity program with 75% performance stock units and 25% time-based restricted stock units.

AEye, Inc. (NASDAQ: LIDR) director Jonathon B. Husby acquired 35,860 shares of the company's common stock on November 19, 2026, according to a recent filing. The shares were purchased at prices ranging from $0.6900 to $0.7050, for a total transaction value of $25,058. Following the purchase, Mr. Husby directly holds 130,468 shares of AEye common stock.

The insider buy arrives as AEye's stock trades near its 52-week low of $0.67. Over the past year, the shares have declined roughly 71%. According to InvestingPro analysis, the stock appears undervalued at current levels, and the company holds more cash than debt on its balance sheet despite a weak overall financial health score.

In other recent developments, AEye reported third-quarter 2026 financial results that delivered a mixed picture. The company exceeded Wall Street's expectations for earnings, posting an adjusted loss per share of $0.15 compared with the anticipated $0.18 loss. Revenue, however, came in at $506,000 against the forecasted $566,670, falling short of estimates. AEye noted that the quarter was its strongest commercial quarter in history, with revenue increasing tenfold from the previous year and 2.5 times from the prior quarter.

Separately, AEye's Board of Directors approved a 2027 executive equity program. The program includes equity awards for certain executives, such as CEO Matthew Fisch and CFO Conor B. Tierney, under the company's 2021 Equity Incentive Plan. The awards consist of 75% performance stock units and 25% time-based restricted stock units.

These recent developments reflect AEye's ongoing strategic and financial activities.

Risks

  • AEye's stock is near its 52-week low and has declined significantly over the past year, indicating persistent market pressure.
  • The company's Q3 revenue fell short of forecasts, and its overall financial health score is weak, despite holding more cash than debt.
  • The 2027 executive equity program ties a majority of awards to performance stock units, which may depend on future operational targets.

More from Insider Trading

Nektar Therapeutics R&D Chief Offloads Shares to Cover Tax Obligations Nov 19, 2026 nLIGHT Accounting Chief Offloads 180 Shares Under Pre-Set Trading Plan Nov 19, 2026 Saba Capital Adds to BNY Mellon Strategic Municipals Stake with $430,818 Purchase Nov 19, 2026 Magnite Director Paul Caine Offloads $500,853 in Shares Nov 19, 2026 Intuitive Machines Insider Sale Tied to RSU Tax Withholding as Shares Retreat Nov 19, 2026